Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 24% ± 4% | |
dendritic cell | 3 studies | 18% ± 2% |
Insufficient scRNA-seq data for expression of THAP1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 504.02 | 1445 / 1445 | 100% | 11.18 | 183 / 183 |
ovary | 100% | 443.31 | 180 / 180 | 100% | 13.58 | 430 / 430 |
uterus | 100% | 526.49 | 170 / 170 | 100% | 11.23 | 459 / 459 |
thymus | 100% | 486.06 | 653 / 653 | 100% | 14.66 | 604 / 605 |
prostate | 100% | 426.73 | 245 / 245 | 100% | 10.35 | 501 / 502 |
breast | 100% | 454.51 | 458 / 459 | 100% | 16.02 | 1118 / 1118 |
brain | 100% | 391.87 | 2634 / 2642 | 100% | 11.98 | 705 / 705 |
liver | 100% | 352.91 | 226 / 226 | 99% | 6.98 | 402 / 406 |
kidney | 100% | 374.33 | 89 / 89 | 99% | 9.94 | 889 / 901 |
bladder | 100% | 560.67 | 21 / 21 | 99% | 9.91 | 497 / 504 |
stomach | 99% | 348.98 | 357 / 359 | 99% | 10.59 | 282 / 286 |
intestine | 100% | 544.87 | 966 / 966 | 98% | 10.14 | 516 / 527 |
lung | 98% | 372.26 | 564 / 578 | 100% | 11.91 | 1155 / 1155 |
adrenal gland | 100% | 467.08 | 258 / 258 | 97% | 7.47 | 224 / 230 |
pancreas | 97% | 263.47 | 319 / 328 | 99% | 8.59 | 177 / 178 |
skin | 98% | 424.68 | 1781 / 1809 | 94% | 8.97 | 445 / 472 |
adipose | 100% | 470.36 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 488.82 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 11.89 | 29 / 29 |
spleen | 100% | 474.08 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 10.20 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.75 | 1 / 1 |
muscle | 100% | 536.88 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 371.51 | 850 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 80% | 3.87 | 64 / 80 |
peripheral blood | 75% | 325.22 | 696 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006351 | Biological process | DNA-templated transcription |
GO_0001935 | Biological process | endothelial cell proliferation |
GO_0007346 | Biological process | regulation of mitotic cell cycle |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0005654 | Cellular component | nucleoplasm |
GO_0001650 | Cellular component | fibrillar center |
GO_0016605 | Cellular component | PML body |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | THAP1 |
Protein name | THAP domain-containing protein 1 |
Synonyms | |
Description | FUNCTION: DNA-binding transcription regulator that regulates endothelial cell proliferation and G1/S cell-cycle progression. Specifically binds the 5'-[AT]NTNN[GT]GGCA[AGT]-3' core DNA sequence and acts by modulating expression of pRB-E2F cell-cycle target genes, including RRM1. Component of a THAP1/THAP3-HCFC1-OGT complex that is required for the regulation of the transcriptional activity of RRM1. May also have pro-apoptotic activity by potentiating both serum-withdrawal and TNF-induced apoptosis. . FUNCTION: DNA-binding transcription regulator that regulates endothelial cell proliferation and G1/S cell-cycle progression. Specifically binds the 5'-[AT]NTNN[GT]GGCA[AGT]-3' core DNA sequence and acts by modulating expression of pRB-E2F cell-cycle target genes. . |
Accessions | Q9NVV9 ENST00000345117.2 [Q9NVV9-2] ENST00000254250.7 [Q9NVV9-1] E9PIS9 ENST00000529779.1 |